New Contaminant Testing Method from Applied Biosystems/MDS SCIEX Developed To Help Improve Food Safety

    Applied Biosystems/MDS SCIEX responds to new issues of global food

    FOSTER CITY, CALIF., June 5 /CNW/ - Applied Biosystems (NYSE:   ABI), an
Applera Corporation business, and its joint venture partner, Sciex, a division
of MDS Inc.'s Analytical Technologies business, (NYSE:   MDZ, TSX: MDS), today
announced the release of a new food testing method intended to help public
health laboratories and food manufacturers improve food safety. Multiple
federal agencies, including the U.S. Food & Drug Administration, the U.S.
Department of Agriculture and U.S. Customs & Border Protection, continue
comprehensive, science-based investigations to ensure human and animal health
are protected from contaminants recently identified in animal feed and pet

    The new method to test for the chemicals melamine and cyanuric acid,
called Food Testing Method for Melamine and Cyanuric Acid, is designed to
increase the accuracy and reduce the amount of time to identify the harmful
food contaminants melamine and cyanuric acid from 30 minutes to less than six
minutes.(2) This new method is based on a scientific technology called liquid
chromatography-mass spectrometry, which is used in laboratories for molecular
analysis, including food testing. The Food Testing Method for Melamine and
Cyanuric Acid is the first commercially available method to test for both
contaminants simultaneously with this advanced technology.

    Researchers at the University of Guelph's Agriculture and Food Laboratory
in Ontario, Canada were among the first scientists to identify melamine in
tainted pet food in North America this year and to verify the need to test for
cyanuric acid. Melamine is an industrial chemical used in plastics and
fertilizer. Cyanuric acid is a chemical used in outdoor swimming pools and hot
tubs. The concern that the harm of crystals formed from melamine and cyanuric
acid, as identified in the kidneys of several pets that died this year, could
extend to affect animals that humans consume - such as chickens and hogs - has
driven the need for broader assessments of food safety.

    The team of researchers at the University of Guelph provided input to
assist Applied Biosystems/MDS SCIEX in defining the requirements for the new
method intended for standardized use in laboratories performing food testing
in accordance with regulatory requirements. The researchers standardized their
food testing laboratory on Applied Biosystems/MDS SCIEX's mass spectrometry
technology to analyze food chemical contaminants.

    "The best available technologies, methods, and insight need to be applied
to accurately determine whether or not food is safe," said Perry Martos, a
researcher at the University of Guelph. "If public confidence in the safety of
the food supply is to be widely restored, food testing globally needs to
become faster and more consistent. Applied Biosystems/MDS SCIEX's new food
contaminant testing method is a step in the right direction to get food
analysis technicians to the most reliable results as soon as possible in every

    Applied Biosystems/MDS SCIEX developed this new method as a means of
assisting laboratories to test for melamine and cyanuric acid in a single
analysis with immediate confirmation of accurate results. By using this
method, technicians can analyze a broader range of food in less time. Other
techniques, such as gas chromatography-mass spectrometry, require extensive
sample preparation and longer run times. Applied Biosystems/MDS SCIEX's mass
spectrometers eliminate this complexity and give users the ability to more
efficiently take advantage of the high sensitivity and selectivity of liquid
chromatography-mass spectrometry for increased accuracy.

    "Food safety is a critically important issue that needs to be addressed
from regulatory, production and scientific perspectives," said Laura Lauman,
president for Applied Biosystems' proteomics and small molecules division. "By
delivering an advanced science-based food testing method to increase
efficiency and accuracy of results, Applied Biosystems/MDS SCIEX continues to
play an active role in assisting government agencies and food producers to
ensure a safe food supply."

    The new method is being delivered through a software application suite
known as Cliquid(TM) Software for Routine Food Testing from Applied
Biosystems/MDS SCIEX. The Cliquid software provides a simple process to use
advanced mass spectrometry systems for routine food testing. Cliquid Software
for Routine Food Testing increases the precision and comprehensiveness of food
contaminant testing, while also simplifying the process for routine analysis.
Laboratories have used Cliquid software to test for other food contaminants,
such as pesticides, dyes and mold-related toxins, in addition to chemical and
antibiotic residues.

    "It is critical that routine food testing deliver precision and
reliability in a simple process to improve food safety over the long term,"
said Andy Boorn, president for MDS Analytical Technologies. "Applied
Biosystems/MDS SCIEX has advanced food testing to the stage where laboratory
technicians without specialized training in mass spectrometry can get all the
benefits of the increased accuracy, without the complexity."

    For more information, please visit the following web page:

    About Applera Corporation and Applied Biosystems

    Applera Corporation consists of two operating groups. The Applied
Biosystems Group serves the life science industry and research community by
developing and marketing instrument-based systems, consumables, software, and
services. Customers use these tools to analyze nucleic acids (DNA and RNA),
small molecules, and proteins to make scientific discoveries and develop new
pharmaceuticals. Applied Biosystems' products also serve the needs of some
markets outside of life science research, which we refer to as "applied
markets," such as the fields of: human identity testing (forensic and
paternity testing); biosecurity, which refers to products needed in response
to the threat of biological terrorism and other malicious, accidental, and
natural biological dangers; and quality and safety testing, for example in
food and the environment. Applied Biosystems is headquartered in Foster City,
CA, and reported sales of $1.9 billion during fiscal 2006. The Celera Group is
primarily a molecular diagnostics business that is using proprietary genomics
and proteomics discovery platforms to identify and validate novel diagnostic
markers, and is developing diagnostic products based on these markers as well
as other known markers. Celera maintains a strategic alliance with Abbott for
the development and commercialization of molecular, or nucleic acid-based,
diagnostic products, and it is also developing new diagnostic products outside
of this alliance. Through its genomics and proteomics research efforts, Celera
is also discovering and validating therapeutic targets, and it is seeking
strategic partnerships to develop therapeutic products based on these
discovered targets. Information about Applera Corporation, including reports
and other information filed by the company with the Securities and Exchange
Commission, is available at, or by telephoning
800.762.6923. Information about Applied Biosystems is available at

    About MDS Inc.

    MDS Inc. (TSX: MDS; NYSE:   MDZ) is a global life sciences company that
provides market-leading products and services that our customers need for the
development of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments. MDS has more
than 6,200 highly skilled people in 28 countries. Find out more at or by calling 1-888-MDS-7222, 24 hours a day.

    About Sciex

    Sciex is a division of MDS Analytical Technologies. The Sciex product
portfolio offers proven market leadership in mass spectrometry through its
joint ventures with two of the world's leading analytical instrumentation and
life sciences companies, Applied Biosystems, a business of the Applera
Corporation and PerkinElmer Inc. Find out more at

    Applied Biosystems Forward Looking Statements

    Certain statements in this press release are forward-looking. These may
be identified by the use of forward-looking words or phrases such as "should,"
"expect," and "planned," among others. These forward-looking statements are
based on Applera Corporation's current expectations. The Private Securities
Litigation Reform Act of 1995 provides a "safe harbor" for such
forward-looking statements. In order to comply with the terms of the safe
harbor, Applera Corporation notes that a variety of factors could cause actual
results and experience to differ materially from the anticipated results or
other expectations expressed in such forward-looking statements. These factors
include but are not limited to: (1) rapidly changing technology and dependence
on the development and customer acceptance of new products; (2) sales
dependent on customers' capital spending policies and government-sponsored
research; and (3) other factors that might be described from time to time in
Applera Corporation's filings with the Securities and Exchange Commission. All
information in this press release is as of the date of the release, and
Applera does not undertake any duty to update this information, including any
forward-looking statements, unless required by law.


    1. FDA web site:

    2. The reduction of time from 30 minutes to less than six minutes is
based on Applied Biosystems/MDS SCIEX's lab results on LC/MS/MS technology.

    Applied Biosystems, AB (Design), Applera and Celera are registered
trademarks of Applera Corporation or its subsidiaries in the US and/or certain
other countries. Cliquid is a trademark of Applied Biosystems/MDS SCIEX, a
joint venture between Applera Corporation and MDS Inc. Copyright(C) 2007.
Applera Corporation and MDS Inc. All rights reserved.

For further information:

For further information: Media Anthony Petrucci 508.383.7961 or Investors Peter Dworkin
650.554.2479 or MDS Inc. Media Catherine Melville
416.675.6777 ext. 32265 or MDS Inc. Investors
Sharon Mathers 416.675.6777 ext. 34721

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890